Other
Mesenchymal Stem Cell
0
Pipeline Programs↗
18
Active Trials↗
2
Companies Involved↗
Mesenchymal Stem Cell is an early-stage landscape with 0 programs across 2 companies. The most active players are Taiwan Bio Therapeutics Inc., Hope Biosciences LLC.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
61
clinical trials
Completed21 · 34%
Recruiting15 · 25%
Unknown status12 · 20%
Withdrawn4 · 7%
Terminated3 · 5%
Suspended3 · 5%
Other3 · 5%
Clinical Trials
Trial Activity
61 trials
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS
Recruiting·TThe Foundation for Orthopaedics and Regenerative Medicine·Phase 1·NCT05003388·15 enrolled
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus
Recruiting·TThe Foundation for Orthopaedics and Regenerative Medicine·Phase 1·NCT05018858·15 enrolled
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF
Recruiting·TThe Foundation for Orthopaedics and Regenerative Medicine·Phase 1·NCT05016817·20 enrolled
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty
Recruiting·TThe Foundation for Orthopaedics and Regenerative Medicine·Phase 1·NCT05018767·86 enrolled
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IBD
Recruiting·TThe Foundation for Orthopaedics and Regenerative Medicine·Phase 1·NCT05003947·15 enrolled
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CP
Recruiting·TThe Foundation for Orthopaedics and Regenerative Medicine·Phase 1·NCT05018819·15 enrolled
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosomes for Parkinson's Disease
Recruiting·TThe Foundation for Orthopaedics and Regenerative Medicine·Phase 1·NCT05152394·20 enrolled
Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis
Recruiting·TThe First Affiliated Hospital with Nanjing Medical University·Phase 1·NCT04592640·9 enrolled
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for RA
Recruiting·TThe Foundation for Orthopaedics and Regenerative Medicine·Phase 1·NCT05003934·20 enrolled
Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female
Recruiting·VVinmec Research Institute of Stem Cell and Gene Technology·Phase 2·NCT05329662·130 enrolled
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD
Recruiting·TThe Foundation for Orthopaedics and Regenerative Medicine·Phase 1·NCT05018845·20 enrolled
Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients
Recruiting·—·Phase 1/2·NCT06492798·76 enrolled
Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency
Recruiting·VVinmec Research Institute of Stem Cell and Gene Technology·Phase 1/2·NCT05345418·158 enrolled
Page 1 of 5
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)